Urogen Pharma Ltd. (URGN)
NASDAQ · Healthcare
Urogen Pharma Ltd. Long Term Debt 2016–2025
Urogen Pharma Ltd. annual/quarterly long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Urogen Pharma Ltd. long term debt for the quarter ending December 31, 2025 were 125.0M, a 2.68% increase year-over-year.
- Urogen Pharma Ltd. long term debt for 2025 were 125.0M, a 2.68% increase from 2024.
- Urogen Pharma Ltd. long term debt for 2024 were 121.7M, a 23.52% increase from 2023.
- Urogen Pharma Ltd. long term debt for 2023 were 98.6M, a 1.04% increase from 2022.
- Urogen Pharma Ltd. long term debt for 2022 were 97.5M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Urogen Pharma Ltd. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $125 |
| 2024 | $122 |
| 2023 | $99 |
| 2022 | $98 |
| Urogen Pharma Ltd. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $125 |
| 2024-12-31 | $122 |
| 2023-12-31 | $99 |
| 2022-12-31 | $98 |
Urogen Pharma Ltd. Long Term Debt — FAQ
Urogen Pharma Ltd. (URGN) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see URGN's long term debt history?
The chart and table above show Urogen Pharma Ltd.'s long term debt by year and by quarter, including the growth rate.